levonorgestrel butanoate (HRP002) / NICHD Neonatal Research Network, CONRAD - LARVOL DELTA

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception (clinicaltrials.gov) - P1 | N=136 | Active, not recruiting | Sponsor: Premier Research | Recruiting ➔ Active, not recruiting | Trial completion date: Sep 2024 ➔ Mar 2026 | Trial primary completion date: Sep 2024 ➔ Mar 2026

Enrollment closed • Trial completion date • Trial primary completion date

A Study to Evaluate the Efficacy and Safety of Subcutaneous Levonorgestrel Butanoate for Female Contraception (clinicaltrials.gov) - P2 | N=165 | Not yet recruiting | Sponsor: Premier Research

New P2 trial

A prospective, multicenter, randomized, non-inferiority, controlled, study to evaluate the safety and efficacy of percutaneous ventricular assist systems for high-risk PCI (ChiCTR) - P3 | N=250 | Recruiting | Sponsor: Zhongshan Hospital Affiliated to Fudan University; Forqaly Medical Co., Ltd

New P3 trial

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception (clinicaltrials.gov) - P1 | N=136 | Recruiting | Sponsor: Health Decisions | Trial completion date: May 2023 ➔ Sep 2024 | Trial primary completion date: May 2023 ➔ Sep 2024

Trial completion date • Trial primary completion date

A Study to Evaluate the PK and PD of IM or SQ Injections of Levonorgestrel Butanoate (LB) for Female Contraception (clinicaltrials.gov) - P1; N=160; Recruiting; Sponsor: Health Decisions; Not yet recruiting ➔ Recruiting; Trial completion date: May 2025 ➔ May 2023; Trial primary completion date: May 2025 ➔ May 2023

Enrollment open • Trial completion date • Trial primary completion date